Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors

J Infect. 2023 Apr;86(4):e107-e110. doi: 10.1016/j.jinf.2023.02.007. Epub 2023 Feb 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19*
  • Humans
  • Ritonavir / therapeutic use

Substances

  • nirmatrelvir
  • Ritonavir
  • Antiviral Agents